An experimental cancer test that examines blood proteins instead of tumor DNA has shown promise in detecting early-stage cancers. In a trial involving 440 humans with 18 different cancers, the test achieved high sensitivity and specificity rates. At the earliest cancer stage, the test was able to identify 93% of cancers among males and 84% among females. The researchers suggest that this test could pave the way for a cost-effective, accurate, and population-wide screening test for multiple cancers. Larger trials are needed to confirm the findings, but the potential impact is significant in improving early detection and saving lives.
Balanced News: Sample Page Title
Our 'quick read' news summary
Read different perspectives from these news sources
Searching for related articles, please check back here later!
More top reads from Balanced News Summary
- Advertisment -